Dividend Details

AAREY DRUGS & PHARMACEUTICALS LTD.

NSE : AAREYDRUGSBSE : 524412ISIN CODE : INE198H01019Industry : Pharmaceuticals & DrugsHouse : Aarey
BSE53.452.54 (+4.99 %)
PREV CLOSE ( ) 50.91
OPEN PRICE ( ) 52.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 38892
TODAY'S LOW / HIGH ( )49.31 53.45
52 WK LOW / HIGH ( )26.82 68
NSE53.252.5 (+4.93 %)
PREV CLOSE( ) 50.75
OPEN PRICE ( ) 51.45
BID PRICE (QTY) 53.25 (4270)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 117198
TODAY'S LOW / HIGH( ) 50.75 53.25
52 WK LOW / HIGH ( )27 68

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.